TSX · CURA.TO
Curaleaf Holdings, Inc.
CA$11.75-CA$0.38 (-3.13%)
Curaleaf Holdings, Inc.’s quoted price sits in the lower half of its reported 52-week range, 43.89% below the high.
Loading market information…
OTC · AAWH · USD
Stock price, earnings
Quote as of Oct 30, 2026, 07:15 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Ascend Wellness Holdings, Inc.’s quoted price sits in the lower half of its reported 52-week range, 68.27% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Ascend Wellness Holdings, Inc.’s next earnings report is currently expected on Nov 12, 2026, with estimated earnings per share of -$0.07. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Ascend Wellness Holdings, Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Ascend Wellness Holdings, Inc. operates within the cannabis industry, specializing in the cultivation, processing, and distribution of packaged marijuana products. Its extensive product portfolio encompasses a variety of cannabis forms, including dried flower, pre-rolled joints, concentrated extracts, vaporizable products, edibles, and other related consumer items. As of December 31, 2021, the company maintained a substantial retail presence, with 20 dispensaries in operation. Beyond its own network, Ascend Wellness Holdings additionally supplies its merchandise to other authorized cannabis retailers. Established in 2018, the firm's corporate headquarters are located in New York, New York.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 07:32 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| Q1 2025 | May 12, 2025 | -$0.09-12.5% vs estimate | $128.00M-1.53% vs estimate |
|---|
| Q4 2024 | Mar 12, 2025 | -$0.08+20.0% vs estimate | $136.01M-2.49% vs estimate |
|---|
| Q3 2024 | Nov 12, 2024 | -$0.13-30.0% vs estimate | $141.65M+1.14% vs estimate |
|---|
THE ANALYST VIEW
5 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CA$11.75-CA$0.38 (-3.13%)
Curaleaf Holdings, Inc.’s quoted price sits in the lower half of its reported 52-week range, 43.89% below the high.
CA$6.91-CA$0.37 (-5.08%)
Verano Holdings Corp’s quoted price sits in the lower half of its reported 52-week range, 48.05% below the high.
$6.95-$0.95 (-12.03%)
Vireo Growth Inc.’s quoted price sits in the lower half of its reported 52-week range, 68.05% below the high.
CA$0.25+CA$0.02 (+6.52%)
Vext Science, Inc.’s quoted price sits in the lower half of its reported 52-week range, 38.75% below the high.
CA$0.11-CA$0.01 (-8.7%)
Planet 13 Holdings Inc.’s quoted price sits in the lower half of its reported 52-week range, 80.91% below the high.
CA$0.01CA$0.00 (0.0%)
iAnthus Capital Holdings, Inc.’s quoted price sits in the lower half of its reported 52-week range, 50.0% below the high.
$0.05-$0.00 (-0.19%)
MariMed Inc.’s quoted price sits in the lower half of its reported 52-week range, 66.94% below the high.
$0.00-$0.00 (-20.83%)
Cannabis Strategic Ventures’s quoted price sits in the lower half of its reported 52-week range, 95.77% below the high.
